These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6658716)

  • 21. Conformational changes accompanying the binding of antithrombin III to thrombin.
    Villanueva G; Danishefsky I
    Biochemistry; 1979 Mar; 18(5):810-7. PubMed ID: 420817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor.
    Danishefsky I; Tzeng F; Ahrens M; Klein S
    Thromb Res; 1976 Feb; 8(2):131-40. PubMed ID: 56053
    [No Abstract]   [Full Text] [Related]  

  • 23. Further studies of the turnover of dog antithrombin III. Study of 131I-labelled antithrombin protease complexes.
    Leonard B; Bies R; Carlson T; Reeve EB
    Thromb Res; 1983 Apr; 30(2):165-77. PubMed ID: 6868021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
    Lollar P; Owen WG
    J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rate of the thrombin/antithrombin III reaction is determined with their molar ratio rather than their absolute concentrations.
    Oshima G; Nagasawa K
    Thromb Res; 1987 Apr; 46(2):263-70. PubMed ID: 3603424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte receptors for antithrombin III-proteinase complexes.
    Fuchs HE; Shifman MA; Michalopoulos G; Pizzo SV
    J Cell Biochem; 1984; 24(3):197-206. PubMed ID: 6330134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

  • 28. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin III Sudbury: an Ala384----Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis.
    Pewarchuk WJ; Fernandez-Rachubinski F; Rachubinski RA; Blajchman MA
    Thromb Res; 1990 Aug; 59(4):793-7. PubMed ID: 2093312
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybrene.
    Oshima G
    Thromb Res; 1988 Sep; 51(6):565-74. PubMed ID: 3187966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine and primary amines inhibit the internalization of antithrombin III.trypsin complex in cultured cells.
    Savion N; Farzame N
    Thromb Res; 1985 Sep; 39(6):671-82. PubMed ID: 3909504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction and thermal stability of fluorescent labeled derivatives of thrombin and antithrombin III.
    Atha DH; Brew SA; Ingham KC
    Biochim Biophys Acta; 1984 Feb; 785(1-2):1-6. PubMed ID: 6696918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin.
    Bezeaud A; Denninger MH; Guillin MC
    Eur J Biochem; 1985 Dec; 153(3):491-6. PubMed ID: 3000780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of thrombin by antithrombin III on a heparinized biomaterial.
    Goosen MF; Sefton MV; Hatton MW
    Thromb Res; 1980 Dec 1-15; 20(5-6):543-54. PubMed ID: 7233384
    [No Abstract]   [Full Text] [Related]  

  • 40. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.